Skip to content

Establishment of a scoring system for predicting postangioplasty restenosis of arteriovenous fistulas and observation on the clinical effect of external treatment with Sanhuang Ointment

Establishment of a scoring system for predicting postangioplasty restenosis of arteriovenous fistulas and observation on the clinical effect of external treatment with Sanhuang Ointment

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003399
Enrollment
Unknown
Registered
2020-05-18
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maintenance hemodialysis

Interventions

Sponsors

Traditional Chinese Medicine Hospital of Hangzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Maintenance hemodialysis patients with AVF established for more than 3 months; 2. Patients aged >= 18 years; 3. Patients with type I stenosis located near the anastomotic site; 4. Patients who received PTA for the first time; 5. Patients who cooperate with treatment and follow-up and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with infection, malignant tumor, acute cardiovascular and cerebrovascular events, severe gastrointestinal bleeding or liver disease need to be hospitalized; 2. In the patients with advanced AVF, the internal fistula can not be punctured normally for more than 6 months; 3. Patients with simultaneous central venous catheter; 4. Patients who need to use cutting balloon, medicine coated balloon, stent placement or surgery for PTA failure; 5. Patients with stenosis located at the puncture site of internal fistula and unable to change the puncture site; 6. The subjects were allergic or intolerant to Sanhuang Ointment or fir; 7. The subjects were undergoing hemodialysis and peritoneal dialysis; 8. Subjects are participating in other clinical trials related to vascular access.

Design outcomes

Primary

MeasureTime frame
Risk factor weight score;Primary patency;

Countries

China

Contacts

Public ContactGuoming Yao

Traditional Chinese Medicine Hospital of Hangzhou

hzyaogm@126.com+86 13958176952

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026